FDA allowed marketing of the first diagnostic device based on brain function
Leo Sher, M.D. The U.S. Food and Drug Administration permitted marketing of the first device based on brain function to help diagnose attention-deficit/hyperactivity disorder (ADHD) in children and adolescents 6 to 17 years old. The device can help establish an ADHD diagnosis. It should be used as part of a complete medical and psychological evaluation. The […]
